Galapagos NV
GLPG
#4562
Rank
NZ$3.75 B
Marketcap
NZ$56.40
Share price
-1.20%
Change (1 day)
22.12%
Change (1 year)

EPS for Galapagos NV (GLPG)

EPS in 2025 (TTM): NZ-$0.80

According to Galapagos NV's latest financial reports the company's current EPS (TTM) is NZ-$0.57. In 2024 the company made an earnings per share (EPS) of NZ$1.95 a decrease over its 2023 EPS that were of NZ$5.93.

EPS history for Galapagos NV from 2004 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ-$0.80-140.88%
2024NZ$1.95-67.16%
2023NZ$5.93-199.64%
2022NZ-$5.9599.03%
2021NZ-$2.99-68.98%
2020NZ-$9.63-298.06%
2019NZ$4.86-554.64%
2018NZ-$1.07-77.18%
2017NZ-$4.69-326.21%
2016NZ$2.07-134.19%
2015NZ-$6.06-371.34%
2014NZ$2.23-445.98%
2013NZ-$0.6532.88%
2012NZ-$0.49-82.07%
2011NZ-$2.71-817.9%
2010NZ$0.3812.73%
2009NZ$0.33-120.79%
2008NZ-$1.61-37.67%
2007NZ-$2.5839.64%
2006NZ-$1.8528.17%
2005NZ-$1.446.25%
2004NZ-$1.36

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$18.60-3,384.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
NZ$6.26-1,205.50%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
NZ$3.99-805.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$3.45-708.98%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
NZ$12.20-2,254.65%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
NZ$8.94-1,677.63%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
NZ$6.29-1,211.13%๐Ÿ‡ฌ๐Ÿ‡ง UK
Fortress Biotech
FBIO
NZ-$1.02 79.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
NZ$2.07-465.66%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel